Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Radiofrequency Balloon Catheter Market Outlook (2022 to 2032)

The radiofrequency balloon catheter market is anticipated to exhibit growth at a 5.5% CAGR over the assessment period, surpassing US$ 50 Billion in 2022. The rising incidence of atrial fibrillation and pulmonary vein isolation is expected to underpin demand in the market. Additionally, radiofrequency balloon catheters have been proven to be safe and effective, which is propelling their adoption in the healthcare sector.

Report Attribute Details
Radiofrequency Balloon Catheter Market Size (2022) US$ 50 Billion
Radiofrequency Balloon Catheter Market Projected Growth Rate (2022 to 2032) 5.5%

Manufacturers are currently developing radiofrequency balloon catheters; the plans for which are in the pipeline. For instance, Biosense Webster, Inc. has developed a multi-electrode radiofrequency balloon catheter for the treatment of symptomatic paroxysmal atrial fibrillation. Such developments are expected to bode well for the market.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Which Factors are Fueling Sales of Radiofrequency Balloon Catheter?

Rising cases of atrial fibrillation are placing a critical burden on the healthcare sector. According to the CDC, in 2030, an estimated 12.1 million people will suffer from atrial fibrillation in the USA

Applications of radiofrequency balloon catheters are expected to increase for the treatment of atrial fibrillation and pulmonary vein isolation. These devices are used to examine atrial fibrillation and are designed to optimize efficacy and safety and reduce treatment time. The radiofrequency energy of the radiofrequency balloon catheter helps the catheters move from the femoral vein to the left atrium and assists in examining atrial fibrillation.

With the advancement of technology and increasing investments in the healthcare sector, the adoption of radiofrequency balloon catheters will rise. In addition to this, the launch of new and advanced radiofrequency balloon catheters will also foster growth in the radiofrequency balloon catheter market

Which Factors Limiting the Growth of the Radiofrequency Balloon Catheter Market?

There are certain factors that may hamper the growth of the radiofrequency balloon catheter market. Radiofrequency balloon catheters require a skilled trainer to know and use the devices well since they require more functions to operate the devices.

A lack of skilled professionals and well-trained healthcare professionals may impede the growth of the radiofrequency balloon catheter market. Further, the rate of reproduction is less as compared to a cryoballoon.

The cost of the radiofrequency balloon catheter is high in comparison to other catheters. These factors are expected to limit sales in the market over the forecast period.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What is the North America Balloon Catheter Market Outlook?

North America is predicted to witness growth at a considerable pace over the forecast period. Due to the rising adoption of new and advanced technologies, manufacturers are launching technologically-advanced radiofrequency balloon catheters.

The USA and Canada have recorded an increase in the incidence of chronic disorders owing to sedentary lifestyles. Additionally, the rising number of patients undergoing surgeries, and growing awareness of minimally invasive surgeries are factors that are anticipated to propel sales.

According to CDC, heart diseases account for one in every four deaths in the USA Each year there are about 659,000 deaths related to cardiovascular diseases in the USA Obesity, poor lifestyle habits such as a poor diet, physical inactivity, excessive alcohol intake, smoking, hypertension, and high cholesterol levels are some factors that cause cardiovascular diseases. About 50% of Americans exhibit at least one of these behavioral risk factors.

According to the IHME report published in 2017, ischemic heart disease was the leading cause of death and disability in Canada. Therefore, the rising incidence of peripheral artery disease, occlusions in blood vessels, and awareness of minimally invasive surgeries may boost demand for catheters in Canada.

How are Increasing Investments in the Healthcare Sector Augmenting Growth in the Asia Pacific Market?

Growing awareness among individuals about heart diseases, early diagnosis, and minimally invasive treatment options will underscore the requirement for radiofrequency balloon catheters across the Asia Pacific.

Significant growth can also be noted in the Japan radiofrequency balloon catheter market. This is owing to increased interest and investment in research and development of new healthcare facilities and treatment options. In addition to this, rising cases of atrial fibrillation in the country will augment the adoption of radiofrequency balloon catheters in the forthcoming years.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Market Competition

Some of the leading players operating in the radiofrequency balloon catheter market are Medtronic, and Biosense Webster, Inc.

These players are investing in research and development activities to incorporate the latest and advanced technologies to improve their product portfolios.

Report Scope

Report Attribute Details
Growth Rate (2022 to 2032) 5.5% CAGR
Base Year for Estimation 2021
Historical Data 2015 to 2021
Forecast Period 2022 to 2032
Quantitative Units Revenue in US$ Million, and CAGR from 2022 to 2032
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
  • Indication
  • End User
  • Region
Countries Covered
  • North America (USA, Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, United Kingdom, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC Countries, S. Africa, N. Africa)
Key Companies Profiled
  • Medtronic
  • Biosense Webster, Inc
Customization Available Upon Request

Key Segments Profiled in the Radiofrequency Balloon Catheter Market Survey

By Indication:

  • Chronic hemorrhagic radiation proctitis
  • Malignant biliary strictures

By End User:

  • Hospitals
  • Clinics
  • Diagnostics Laboratories
  • Others

By Region:

  • North America (USA, Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, United Kingdom, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC Countries, S. Africa, N. Africa)

Frequently Asked Questions

What is driving is the radiofrequency balloon catheter market?

Radiofrequency balloon catheters are used to examine atrial fibrillation. Increasing investments in the expansion of the healthcare infrastructure across emerging economies will drive sales in the market over the assessment period.

Which factors are limiting sales of radiofrequency balloon catheters?

Higher costs of production and a dearth of skilled professionals who are well-versed in the functions of the product are some factors that might hinder the growth in the market.

Who are the leading players in the radiofrequency balloon catheter market?

Key players in the radiofrequency balloon market include Medtronic and Biosense Webster Inc.

Table of Content

1. Executive Summary | Radiofrequency Balloon Catheter Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032

    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Indication

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2017 to 2021

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2022 to 2032

        5.3.1. Chronic Haemorrhagic Radiation Proctitis

        5.3.2. Malignant Biliary Strictures

    5.4. Y-o-Y Growth Trend Analysis By Indication, 2017 to 2021

    5.5. Absolute $ Opportunity Analysis By Indication, 2022 to 2032

6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032

        6.3.1. Hospitals

        6.3.2. Clinics

        6.3.3. Diagnostics Laboratories

        6.3.4. Others

    6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021

    6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032

7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. Asia Pacific

        7.3.5. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        8.2.1. By Country

            8.2.1.1. United Kingdom

            8.2.1.2. Canada

        8.2.2. By Indication

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Indication

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Indication

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Indication

        9.3.3. By End User

    9.4. Key Takeaways

10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. United Kingdom

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Indication

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Indication

        10.3.3. By End User

    10.4. Key Takeaways

11. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

            11.2.1.4. Malaysia

            11.2.1.5. Singapore

            11.2.1.6. Australia

            11.2.1.7. Rest of Asia Pacific

        11.2.2. By Indication

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Indication

        11.3.3. By End User

    11.4. Key Takeaways

12. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        12.2.1. By Country

            12.2.1.1. GCC Countries

            12.2.1.2. South Africa

            12.2.1.3. Israel

            12.2.1.4. Rest of Middle East and Africa

        12.2.2. By Indication

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Indication

        12.3.3. By End User

    12.4. Key Takeaways

13. Key Countries Market Analysis

    13.1. United Kingdom

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2021

            13.1.2.1. By Indication

            13.1.2.2. By End User

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2021

            13.2.2.1. By Indication

            13.2.2.2. By End User

    13.3. Brazil

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2021

            13.3.2.1. By Indication

            13.3.2.2. By End User

    13.4. Mexico

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2021

            13.4.2.1. By Indication

            13.4.2.2. By End User

    13.5. Rest of Latin America

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2021

            13.5.2.1. By Indication

            13.5.2.2. By End User

    13.6. Germany

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2021

            13.6.2.1. By Indication

            13.6.2.2. By End User

    13.7. United Kingdom

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2021

            13.7.2.1. By Indication

            13.7.2.2. By End User

    13.8. France

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2021

            13.8.2.1. By Indication

            13.8.2.2. By End User

    13.9. Spain

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2021

            13.9.2.1. By Indication

            13.9.2.2. By End User

    13.10. Italy

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2021

            13.10.2.1. By Indication

            13.10.2.2. By End User

    13.11. Rest of Europe

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2021

            13.11.2.1. By Indication

            13.11.2.2. By End User

    13.12. China

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2021

            13.12.2.1. By Indication

            13.12.2.2. By End User

    13.13. Japan

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2021

            13.13.2.1. By Indication

            13.13.2.2. By End User

    13.14. South Korea

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2021

            13.14.2.1. By Indication

            13.14.2.2. By End User

    13.15. Malaysia

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2021

            13.15.2.1. By Indication

            13.15.2.2. By End User

    13.16. Singapore

        13.16.1. Pricing Analysis

        13.16.2. Market Share Analysis, 2021

            13.16.2.1. By Indication

            13.16.2.2. By End User

    13.17. Australia

        13.17.1. Pricing Analysis

        13.17.2. Market Share Analysis, 2021

            13.17.2.1. By Indication

            13.17.2.2. By End User

    13.18. Rest of Asia Pacific

        13.18.1. Pricing Analysis

        13.18.2. Market Share Analysis, 2021

            13.18.2.1. By Indication

            13.18.2.2. By End User

    13.19. GCC Countries

        13.19.1. Pricing Analysis

        13.19.2. Market Share Analysis, 2021

            13.19.2.1. By Indication

            13.19.2.2. By End User

    13.20. South Africa

        13.20.1. Pricing Analysis

        13.20.2. Market Share Analysis, 2021

            13.20.2.1. By Indication

            13.20.2.2. By End User

    13.21. Israel

        13.21.1. Pricing Analysis

        13.21.2. Market Share Analysis, 2021

            13.21.2.1. By Indication

            13.21.2.2. By End User

    13.22. Rest of the Middle East and Africa

        13.22.1. Pricing Analysis

        13.22.2. Market Share Analysis, 2021

            13.22.2.1. By Indication

            13.22.2.2. By End User

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Indication

        14.3.3. By End User

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. Medtronic

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segments

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

        15.1.2. Biosense Webster

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segments

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

        15.1.3. Koninklijke Philips

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segments

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

        15.1.4. Abbott Laboratories

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segments

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

        15.1.5. Boston Scientific Corporation

            15.1.5.1. Overview

            15.1.5.2. Product Portfolio

            15.1.5.3. Profitability by Market Segments

            15.1.5.4. Sales Footprint

            15.1.5.5. Strategy Overview

                15.1.5.5.1. Marketing Strategy

        15.1.6. B. Braun Melsungen

            15.1.6.1. Overview

            15.1.6.2. Product Portfolio

            15.1.6.3. Profitability by Market Segments

            15.1.6.4. Sales Footprint

            15.1.6.5. Strategy Overview

                15.1.6.5.1. Marketing Strategy

        15.1.7. Terumo Corporation

            15.1.7.1. Overview

            15.1.7.2. Product Portfolio

            15.1.7.3. Profitability by Market Segments

            15.1.7.4. Sales Footprint

            15.1.7.5. Strategy Overview

                15.1.7.5.1. Marketing Strategy

        15.1.8. Teleflex Incorporated

            15.1.8.1. Overview

            15.1.8.2. Product Portfolio

            15.1.8.3. Profitability by Market Segments

            15.1.8.4. Sales Footprint

            15.1.8.5. Strategy Overview

                15.1.8.5.1. Marketing Strategy

        15.1.9. Nordson Corporation.

            15.1.9.1. Overview

            15.1.9.2. Product Portfolio

            15.1.9.3. Profitability by Market Segments

            15.1.9.4. Sales Footprint

            15.1.9.5. Strategy Overview

                15.1.9.5.1. Marketing Strategy

        15.1.10. Becton, Dickinson, and Company

            15.1.10.1. Overview

            15.1.10.2. Product Portfolio

            15.1.10.3. Profitability by Market Segments

            15.1.10.4. Sales Footprint

            15.1.10.5. Strategy Overview

                15.1.10.5.1. Marketing Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Recommendations

Healthcare

Continuous Peripheral Nerve Block Catheter Market

Published : September 2023

Healthcare

Central Venous Catheter Market

Published : September 2023

Healthcare

Balloon Catheter Market

Published : January 2023

Healthcare

Stent Graft Balloon Catheter Market

Published : November 2022

Explore Healthcare Insights

View Reports

Radiofrequency Balloon Catheter Market